SCHEMBL18911920

SCHEMBL18911920

Cc1cccc(N2c3cc(C)c(C)cc3N(c3cccc(C)c3)C2C2N(c3cccc(C)c3)c3cc(C)c(C)cc3N2c2cccc(C)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.44
HSP90AA1 P07900 1/20 0.43
MGLL Q99685 1/20 0.43
ALDH1A1 P00352 4/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ACHE P22303 1/20 0.41
ALOX5 P09917 2/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
HPGD P15428 2/20 0.38
HSD11B1 P28845 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PAX8 Q06710 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18911912 0.82 RAB9A (0.44) ALDH1A1LMNATP53MAPTHPGD
SCHEMBL18911717 0.81 ALDH1A1 (0.38) ADRB1ALDH1A1LMNATP53MAPT
SCHEMBL18911788 0.80 HTR7 (0.44) HSP90AA1MGLLALDH1A1L3MBTL1TP53
SCHEMBL18911915 0.79 HSP90AA1 (0.35) HSP90AA1ALDH1A1L3MBTL1LMNAMAPT
SCHEMBL18911903 0.79 NOTUM (0.41) ALDH1A1LMNATP53MAPTHPGD
SCHEMBL20071976 0.78 NPC1 (0.41) ADRB1ALDH1A1LMNATP53MAPT
SCHEMBL18911913 0.78 RAB9A (0.39) ADRB1MGLLALDH1A1L3MBTL1ACHE
SCHEMBL18911918 0.78 ADRB1 (0.46) ADRB1ALDH1A1LMNAMAPTHPGD
SCHEMBL18911896 0.76 ADRB1 (0.36) ADRB1HSP90AA1MGLLALDH1A1L3MBTL1
SCHEMBL20071950 0.75 HSD17B10 (0.39) ALDH1A1LMNATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10541260-B2 Organic photoelectric conversion element, optical area sensor, imaging device, and imaging apparatus CANON KABUSHIKI KAISHA (JP) 2020-01-21 US disclosed
US-20180108691-A1 ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, OPTICAL AREA SENSOR, IMAGING DEVICE, AND IMAGING APPARATUS CANON KABUSHIKI KAISHA (JP) 2018-04-19 US disclosed
US-9882148-B2 Organic compound, field element, organic light-emitting element, display apparatus, image information-processing apparatus, lighting apparatus, image-forming apparatus, and exposure apparatus CANON KABUSHIKI KAISHA (JP) 2018-01-30 US disclosed
US-20170155059-A1 ORGANIC COMPOUND, FIELD ELEMENT, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION-PROCESSING APPARATUS, LIGHTING APPARATUS, IMAGE-FORMING APPARATUS, AND EXPOSURE APPARATUS CANON KABUSHIKI KAISHA (JP) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155059-A1 ORGANIC COMPOUND, FIELD ELEMENT, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION-PROCESSING APPARATUS, LIGHTING APPARATUS, IMAGE-FORMING APPARATUS, AND EXPOSURE APPARATUS SCO2, OGFOD1, OXER1 ADRB1 2230/4885HSP90AA1 3786/4885MGLL 4383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.